Disparity in survival benefits of pembrolizumab between Asian and non‐Asian patients with advanced cancers: A systematic review and meta‐regression analysis.
Saved in:
| Title: | Disparity in survival benefits of pembrolizumab between Asian and non‐Asian patients with advanced cancers: A systematic review and meta‐regression analysis. |
|---|---|
| Authors: | Peng, Shang‐Hsuan1 (AUTHOR), Lin, Ching‐Hung2 (AUTHOR), Chen, I‐Chun2 (AUTHOR), Shen, Ying‐Chun2 (AUTHOR), Chang, Dwan‐Ying3 (AUTHOR), Chen, Tom Wei‐Wu3 (AUTHOR), Huang, Shu‐Min3 (AUTHOR), Hu, Fu‐Chang4,5 (AUTHOR), Lu, Yen‐Shen3 (AUTHOR) yslu@ntu.edu.tw |
| Source: | Cancer Medicine. Oct2023, Vol. 12 Issue 19, p20035-20051. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 173116296 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Disparity in survival benefits of pembrolizumab between Asian and non‐Asian patients with advanced cancers: A systematic review and meta‐regression analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Peng%2C+Shang‐Hsuan%22">Peng, Shang‐Hsuan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lin%2C+Ching‐Hung%22">Lin, Ching‐Hung</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+I‐Chun%22">Chen, I‐Chun</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shen%2C+Ying‐Chun%22">Shen, Ying‐Chun</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chang%2C+Dwan‐Ying%22">Chang, Dwan‐Ying</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Tom+Wei‐Wu%22">Chen, Tom Wei‐Wu</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Shu‐Min%22">Huang, Shu‐Min</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hu%2C+Fu‐Chang%22">Hu, Fu‐Chang</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lu%2C+Yen‐Shen%22">Lu, Yen‐Shen</searchLink><relatesTo>3</relatesTo> (AUTHOR)<i> yslu@ntu.edu.tw</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancer+Medicine%22">Cancer Medicine</searchLink>. Oct2023, Vol. 12 Issue 19, p20035-20051. 17p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=173116296 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cam4.6563 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 17 StartPage: 20035 Titles: – TitleFull: Disparity in survival benefits of pembrolizumab between Asian and non‐Asian patients with advanced cancers: A systematic review and meta‐regression analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Peng, Shang‐Hsuan – PersonEntity: Name: NameFull: Lin, Ching‐Hung – PersonEntity: Name: NameFull: Chen, I‐Chun – PersonEntity: Name: NameFull: Shen, Ying‐Chun – PersonEntity: Name: NameFull: Chang, Dwan‐Ying – PersonEntity: Name: NameFull: Chen, Tom Wei‐Wu – PersonEntity: Name: NameFull: Huang, Shu‐Min – PersonEntity: Name: NameFull: Hu, Fu‐Chang – PersonEntity: Name: NameFull: Lu, Yen‐Shen IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: Oct2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 20457634 Numbering: – Type: volume Value: 12 – Type: issue Value: 19 Titles: – TitleFull: Cancer Medicine Type: main |
| ResultId | 1 |
